Press Releases
Press Releases
Boston Scientific’s Carotid Artery Stent approved by FDA
Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT® Monorail® Endoprosthesis for the treatment of patients with carotid artery disease who are at high risk for surgery. The Carotid WALLSTENT Endoprosthesis...
Press Releases
Medtronic Launches New Medical Device that Improves Minimally-Invasive Treatment
Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic (, Inc., today announced the U.S. market launch of the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which makes minimally-invasive treatment of thoracic...
Press Releases
Lee Memorial Health System to Install Agfa HealthCare’s Integrated IMPAX® Radiology &Cardiology PACS
Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, announces today that the Lee Memorial Health System (LMHS) of Southwest Florida has chosen Agfa HealthCare’s IMPAX® Picture Archiving and Communications System (PACS) for its radiology...
Press Releases
Elekta announces installation of Leksell Gamma Knife Perfexion at Haukeland University Hospital in N
Leksell Gamma Knife® Perfexion™ is the latest and most advanced solution on the market for non-invasive treatment of brain disorders. This new generation Leksell Gamma Knife is fully automated and has the ability to treat patients with multiple brain...
Press Releases
Philips Celsion announce agreement to cancer treatment has ultrasound, drug delivery technology
Royal Philips Electronics and Celsion Corporation announced the signing of a joint research agreement focusing on a new cancer treatment that combines Philips’ ultrasound technology with Celsion’s drug delivery solution to target tumors with high concentrations of a cancer-fighting...
Press Releases
Integra LifeSciences launches accel Evo3, the next generation accell technology
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has received 510(k) clearance from the United States Food and Drug Administration to market Accell Evo3(TM) in the US. Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has...
Press Releases
New data shows Abbott’s Bioabsorbable Drug Eluting Stent is absorbed within two years
Abbott announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating that its bioabsorbable drug eluting stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years, leaving behind blood...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read